FDA plans to reduce nicotine in cigarettes
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1606 (Published 29 June 2022) Cite this as: BMJ 2022;377:o1606- Janice Hopkins Tanne
- New York
The US Food and Drug Administration has announced that it plans to establish a maximum level of nicotine in cigarettes. Reducing nicotine will reduce the addictive potential of cigarettes, it said.1
To implement the policy the FDA must first develop a “proposed product standard” to establish the maximum level of nicotine in cigarettes. It announced its plan to do so in a government document outlining planned regulatory actions.2 This process may take a year, after which the FDA will have to consider public comments and issue a final rule, which is likely to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.